↓ Skip to main content

A KCNB1 gain of function variant causes developmental delay and speech apraxia but not seizures

Overview of attention for article published in Frontiers in Pharmacology, December 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A KCNB1 gain of function variant causes developmental delay and speech apraxia but not seizures
Published in
Frontiers in Pharmacology, December 2022
DOI 10.3389/fphar.2022.1093313
Pubmed ID
Authors

Emma L. Veale, Alessia Golluscio, Katheryn Grand, John M. Graham, Alistair Mathie

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 18%
Student > Bachelor 1 9%
Unspecified 1 9%
Student > Postgraduate 1 9%
Other 1 9%
Other 0 0%
Unknown 5 45%
Readers by discipline Count As %
Medicine and Dentistry 2 18%
Biochemistry, Genetics and Molecular Biology 2 18%
Unspecified 1 9%
Unknown 6 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 January 2023.
All research outputs
#6,319,941
of 24,911,633 outputs
Outputs from Frontiers in Pharmacology
#2,697
of 19,047 outputs
Outputs of similar age
#115,695
of 472,086 outputs
Outputs of similar age from Frontiers in Pharmacology
#88
of 997 outputs
Altmetric has tracked 24,911,633 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 19,047 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 472,086 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 997 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.